Zaki I, Emerson R, Allen B R
Department of Dermatology, University Hospital, Nottingham, U.K.
Br J Dermatol. 1996 Sep;135 Suppl 48:21-4. doi: 10.1111/j.1365-2133.1996.tb00705.x.
Cyclosporin has been shown to be effective in the treatment of adult atopic dermatitis, but there are no clinical trials evaluating its use in childhood. Atopic dermatitis is more common in children and the severe form can be associated with considerable morbidity. We report on 18 children with severe refractory atopic dermatitis who have been treated with cyclosporin on an open basis. The drug was given at an initial daily dose of 5 or 6 mg/kg and in some patients the dose was reduced according to response. Sixteen patients showed a good or excellent response to treatment, one a moderate response and one patient failed to improve. The treatment was well tolerated and there were no significant changes in serum creatinine or blood pressure. Long remission after withdrawal of treatment was seen in some patients, although most relapsed within a few weeks. We suggest that cyclosporin is an effective and safe short-term treatment for severe atopic dermatitis in childhood.
环孢素已被证明对成人特应性皮炎有效,但尚无评估其在儿童中应用的临床试验。特应性皮炎在儿童中更为常见,严重形式可能伴有相当高的发病率。我们报告了18例患有严重难治性特应性皮炎的儿童,他们接受了开放性的环孢素治疗。药物初始日剂量为5或6mg/kg,部分患者根据反应减少剂量。16例患者对治疗反应良好或极佳,1例中度反应,1例患者无改善。治疗耐受性良好,血清肌酐或血压无显著变化。部分患者在停药后有较长时间的缓解,但大多数在几周内复发。我们认为环孢素是儿童严重特应性皮炎有效且安全的短期治疗方法。